AntoXa is using the vivoXPRESS® system to produce an innovator antibody (PhD9) being studied by Defence Research and Development Canada (DRDC) as an antidote to ricin exposure.
AntoXa
Life-saving biodefense solutions
Anti-Toxins
Anti-nerve agents
AntoXa awarded federal government contract for anti-nerve agent enzyme
GUELPH, Ontario, Canada, March 20, 2019 — AntoXa Corporation has been awarded a contract with the Government of Canada to continue work on production of plant-made butyrylcholinesterase (BuChE), a protein that provides protection against toxic nerve agents such as sarin and soman. The one-year contract, worth up to $329,395, with a possible extension for two more… Read more >
Antivirals
Antibodies for Ebola
Antibodies produced using the vivoXPRESS® biopharmaceutical manufacturing system have been shown to neutralize the Sudan strain of Ebola as well as antibodies produced using other systems.
News
AntoXa Corporation and SwiftPharma Sign Exclusive Collaboration Agreement to Support the Development and Commercialization of a Plant-Made Antibody Against Ricin Exposure
GHENT, Belgium and TORONTO, Canada, September 5, 2023 – AntoXa Corporation, a ...
Read more >
U.S. Patent Granted for Made-in-Canada Ricin Antibody Technology
GUELPH, Ont., CANADA, Feb. 27, 2023 — The U.S. Patent Office has granted a ...
Read more >
About Us
Plant-made biopharmaceuticals for a safer world.
AntoXa Corporation is a Canadian biopharmaceutical company developing medical countermeasures to protect military and civilian personnel from biological and chemical agents that might be used in terrorist attacks, as well as outbreaks of naturally ...
Read more >
Global Demand for Biodefense Therapeutics
Governments are investing billions of dollars preparing for potential bioterrorism attacks and ...
Read more >
Subscribe to our Newsletter
vivoXPRESS® MANUFACTURING SYSTEM
The plant-based vivoXPRESS® manufacturing platform offers several advantages over the mammalian and bacterial cell culture systems used to produce most recombinant protein pharmaceuticals. Here’s how it works.BioPharming Info Centre
Biopharming, also known as plant molecular farming, refers to the use of genetically modified plants to produce a wide range of pharmaceuticals and industrial products. See our Biopharming Info Centre to Learn more about the science and history of using plants to produce complex therapeutic proteins.